Familial Partial Lipodystrophy
📧 Sign up to get email alerts when something new happens for Familial Partial Lipodystrophy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-11-03EMA Authorised: Myalepta (Metreleptin) — Chiesi Farmaceutici S.p.A.
EMA authorised Myalepta (metreleptin) for lipodystrophy, including familial partial lipodystrophy, with orphan medicine designation; the mar…
-
FDA approval · 2019-12-13FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) filed by Chiesi USA, Inc. This action completes the review of a supple…
-
FDA approval · 2017-12-11FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for MYALEPT (metreleptin) filed by Chiesi USA, Inc.